Clik here to view.
LG Chem Life Sciences and TransThera Biosciences Announce License Agreement...
SEOUL, South Korea & NANJING, China LG Chem Life Sciences (“LG Chem”), a division of LG Chem, and TransThera Biosciences Co. Ltd. (“TransThera”), a clinical-stage biotechnology company based in...
View ArticleClik here to view.
ソウルバイオシス、UV LEDによるvioleds技術でペットのがん診断技術を開発
韓国安山市 （ビジネスワイヤ） — 光半導体専門企業のSeoul Viosys Co., Ltd. (本社：安山市、代表理事：イ・ヨンジュ、以下「ソウルバイオシス」) は、19日、蔚山(ウルサン)大学の研究チームとの臨床実験を通じて、新概念となるペットのがん早期診断技術を開発したと発表した。...
View ArticleClik here to view.
首尔伟傲世将采用Violeds技术开发宠物癌症诊断技术
韩国 安山 (美国商业资讯)–首尔伟傲世(KOSDAQ: 092190)，全球UV LED产品和技术的创新者，该公司已采用其紫外线LED Violeds技术开发出一种用于宠物癌症早期诊断的先进概念技术，并已通过韩国蔚山大学科研团队开展的临床测试。...
View ArticleClik here to view.
Merck’s KEYTRUDA® (pembrolizumab) Receives Two New Approvals in Japan
KENILWORTH, N.J. Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that KEYTRUDA, Merck’s anti-PD-1 therapy, has received two new approvals from the Japan...
View ArticleClik here to view.
Bio-Thera Solutions and BeiGene Announce License, Distribution, and Supply...
GUANGZHOU & BEIJING & CAMBRIDGE, Mass Bio-Thera Solutions, Ltd., a commercial stage biopharmaceutical company (688177.SH) and BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), today announced that...
View ArticleClik here to view.
BeiGene Appoints Corsee Sanders, Ph.D. to its Board of Directors
CAMBRIDGE, Mass. & BEIJING BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, today...
View ArticleClik here to view.
拓臻生物任命Senthil Sundaram为首席执行官、Mark Vignola, Ph.D.为首席财务官、Erin Quirk, M.D.为总裁
加州福斯特城 (美国商业资讯)–拓臻生物（Terns Pharmaceuticals, Inc.）是一家生物制药公司，专注于开发治疗肝病的同类最佳单药和联合用药。公司今天宣布，任命Senthil Sundaram为首席执行官(CEO)兼董事、Mark Vignola, Ph.D.为首席财务官。此外，2019年1月加入拓臻生物担任首席医学官的Erin Quirk,...
View ArticleClik here to view.
Astex Pharmaceuticals Announces That Tolinapant (ASTX660), a Novel Antagonist...
PLEASANTON, Calif. Astex Pharmaceuticals, Inc., a wholly owned subsidiary of Otsuka Pharmaceutical Co., Ltd., based in Tokyo, Japan, announces that the US Food & Drug Administration (FDA) has...
View ArticleClik here to view.
私人集团 RLS (USA) Inc.收购GE医疗的美国放射性药房网络
佛罗里达州坦帕 (美国商业资讯)–RLS (USA) Inc.(Radioisotope Life Sciences)已收购通用电气(GE)的美国放射性药房网络，成为美国最大的专注于纯分子成像的公司。全球性精品金融咨询公司Capitor (www.capitor.co)精心构建该交易并将其带给投资者，在各方历经数年的谈判与协作中发挥了关键作用。财务条款未披露。...
View ArticleClik here to view.
Clik here to view.
Shionogi Granted New Technology Add-on Payment For FETROJA® (Cefiderocol) by CMS
OSAKA, Japan and FLORHAM PARK, N.J. Shionogi & Co., Ltd. (hereafter “Shionogi”) today announces that the Centers for Medicare & Medicaid Services (CMS) has granted a new technology add-on...
View ArticleClik here to view.
BeiGene Announces Inclusion of Its Shares in the Shanghai-Hong Kong and...
BEIJING & CAMBRIDGE, Mass. BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, today...
View ArticleClik here to view.
Fukushima SiC Applied Engineering Inc. Raises USD 30 Million (JPY 3.1...
FUKUSHIMA, Japan Fukushima SiC Applied Engineering Inc., the Naraha, Fukushima headquartered Silicon carbide technology company developing the next generation of BNCT* radiotherapy solutions, has...
View ArticleClik here to view.
Clik here to view.
Zion Pharma Announces Initiation of Phase 1 Study
HONG KONG & SHANGHAI & SUZHOU, China Zion Pharma Limited, an emerging Chinese biotechnology company focused on the development of brain-penetrable compounds, today announced the initiation...
View ArticleClik here to view.
Takeda Divests Select Non-Core Assets in Europe to Cheplapharm for...
OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has entered into an agreement to divest a portfolio of select non-core prescription...
View ArticleClik here to view.
福岛SiC应用技研株式会社在C轮融资中筹得3,000万美元（31亿日元）
日本福岛 (美国商业资讯)–总部位于福岛县楢叶町、正在开发下一代BNCT*放疗解决方案的碳化硅技术公司福岛SiC应用技研株式会社(Fukushima SiC Applied Engineering Inc.)已在C轮融资中筹得3,000万美元（31亿日元），投资者包括C:iz Investment LLP、Japan Post Investment Corporation、Astellas...
View ArticleClik here to view.
Apros Therapeutics Announces IND Clearance from U.S. FDA to Initiate the...
SAN DIEGO Apros Therapeutics, Inc., a drug discovery and development company focused on tissue-targeted Toll-Like Receptor 7 (TLR7) agonists for the treatment of cancer and infectious diseases,...
View ArticleClik here to view.
BeiGene Announces Acceptance and Priority Review by Health Canada of New Drug...
CAMBRIDGE, Mass. & BEIJING BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, today...
View ArticleClik here to view.
S2 Genomics Announces Asia-Pacific Distribution Partnerships for the...
LIVERMORE, Calif. S2 Genomics, Inc., today announced that it has entered into distribution agreements with SCRUM, PharmiGene, LnCBio, Thunderbio Science, and TrendBio for the promotion, sales, and...
View Article